Drug Shortage Report for PDP-ERYTHROMYCIN

Last updated on 2020-09-22 History
Report ID 41037
Drug Identification Number 01912755
Brand name PDP-ERYTHROMYCIN
Common or Proper name pdp-ERYTHROMYCIN 5mg/g OINT OPHT 3.5g
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 5MG
Dosage form(s) OINTMENT
Route of administration OPHTHALMIC
Packaging size 3.5g
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-02-23
Actual start date 2018-02-23
Estimated end date 2021-01-15
Actual end date 2020-09-21
Shortage status Resolved
Updated date 2020-09-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v34 2019-05-31 French Compare
v33 2019-05-31 English Compare
v32 2019-04-17 French Compare
v31 2019-04-17 English Compare
v30 2019-04-03 French Compare
v29 2019-04-03 English Compare
v28 2018-12-18 French Compare
v27 2018-12-18 English Compare
v26 2018-11-23 French Compare
v25 2018-11-23 English Compare
v24 2018-11-02 French Compare
v23 2018-11-02 English Compare
v22 2018-10-04 French Compare
v21 2018-10-04 English Compare
v20 2018-10-02 French Compare
v19 2018-10-02 English Compare
v18 2018-10-02 French Compare
v17 2018-10-02 English Compare
v16 2018-09-07 French Compare
v15 2018-09-07 English Compare

Showing 21 to 40 of 54